Colgate-Palmolive (NYSE:CL) Price Target Raised to $95.00

Posted by Brenda Bartman on Nov 6th, 2026

Colgate-Palmolive (NYSE:CL – Free Report) had its price objective hoisted by Barclays from $87.00 to $95.00 in a research report report published on Tuesday,Benzinga reports. They currently have an equal weight rating on the stock.

CL has been the subject of several other research reports. Evercore lifted their target price on shares of Colgate-Palmolive from $100.00 to $101.00 and gave the stock an “outperform” rating in a report on Thursday, October 8th. Weiss Ratings lowered shares of Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 2nd. Sanford C. Bernstein reissued a “market perform” rating on shares of Colgate-Palmolive in a report on Thursday, August 13th. JPMorgan Chase & Co. cut their price objective on shares of Colgate-Palmolive from $104.00 to $102.00 and set an “overweight” rating for the company in a research report on Monday. Finally, Raymond James Financial raised their price objective on shares of Colgate-Palmolive from $100.00 to $102.00 and gave the stock an “outperform” rating in a research report on Monday, August 3rd. Thirteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $101.22.

Get Our Latest Analysis on Colgate-Palmolive

Colgate-Palmolive Trading Down 0.1%

Shares of Colgate-Palmolive stock opened at $98.68 on Tuesday. The business has a fifty day simple moving average of $90.01 and a two-hundred day simple moving average of $89.92. Colgate-Palmolive has a 1 year low of $75.96 and a 1 year high of $101.18. The company has a market capitalization of $78.44 billion, a price-to-earnings ratio of 25.45, a P/E/G ratio of 4.48 and a beta of 0.31. The company has a debt-to-equity ratio of 11.23, a current ratio of 0.96 and a quick ratio of 0.30.

Colgate-Palmolive (NYSE:CL – Get Free Report) last released its quarterly earnings data on Friday, October 30th. The company reported $0.97 EPS for the quarter, topping analysts’ consensus estimates of $0.93 by $0.04. The firm had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.34 billion. Colgate-Palmolive had a net margin of 9.65% and a return on equity of 607.88%. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.91 earnings per share. Research analysts forecast that Colgate-Palmolive will post 3.91 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be given a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Tuesday, October 20th. Colgate-Palmolive’s payout ratio is presently 83.14%.

Insider Activity

In related news, COO Panagiotis Tsourapas sold 10,000 shares of the company’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $92.05, for a total value of $920,500.00. Following the transaction, the chief operating officer directly owned 64,901 shares in the company, valued at approximately $5,974,137.05. This represents a 13.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.43% of the company’s stock.

Institutional Trading of Colgate-Palmolive

A number of institutional investors have recently bought and sold shares of CL. State Street Corp grew its stake in shares of Colgate-Palmolive by 97.4% in the 2nd quarter. State Street Corp now owns 94,195,992 shares of the company’s stock worth $8,635,889,000 after acquiring an additional 46,476,510 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in shares of Colgate-Palmolive by 8.1% in the second quarter. Bank of New York Mellon Corp now owns 13,532,417 shares of the company’s stock valued at $1,240,652,000 after purchasing an additional 1,010,872 shares during the last quarter. First Eagle Investment Management LLC lifted its position in shares of Colgate-Palmolive by 1.1% during the second quarter. First Eagle Investment Management LLC now owns 8,205,699 shares of the company’s stock valued at $752,298,000 after purchasing an additional 88,917 shares in the last quarter. Amundi lifted its position in shares of Colgate-Palmolive by 19.9% during the second quarter. Amundi now owns 6,218,257 shares of the company’s stock valued at $570,090,000 after purchasing an additional 1,033,918 shares in the last quarter. Finally, Bank of America Corp DE bought a new position in shares of Colgate-Palmolive during the second quarter valued at about $567,483,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive News Roundup

Here are the key news stories impacting Colgate-Palmolive this week:

Positive Sentiment: Several analysts raised their price targets, and BNP Paribas Exane reaffirmed its Outperform rating. The reports include updates from Read More., Read More., Read More., and Read More.. A separate report highlighted Morgan Stanley’s expectation for strong potential appreciation. Morgan Stanley report
Positive Sentiment: Colgate-Palmolive’s defensive consumer-staples profile and dividend history may appeal to investors seeking reliable businesses amid political uncertainty. Its recent quarterly results also beat analyst estimates, as noted in the broader discussion of dividend stocks’ resilience. Dividend Kings article
Neutral Sentiment: Analyst views are not uniformly bullish: Barclays maintained a Hold rating even as other coverage reported a target increase. This points to some optimism about upside but continued caution on valuation or near-term prospects. Barclays rating
Negative Sentiment: Rising oil prices and cautious U.S. consumers are pressuring consumer-goods companies’ margins, a potential headwind for Colgate-Palmolive if costs rise faster than it can pass them through. Dividend-stock comparison
Negative Sentiment: Colgate’s valuation may also weigh on the shares: a comparison with Hershey noted that Hershey trades at a lower forward P/E despite revenue growth, making CL look less attractive to valuation-focused investors. Colgate and Hershey comparison

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.